Mankind Pharma Sees Significant Open Interest Surge Amid Increased Market Activity
Mankind Pharma Ltd has seen a significant rise in open interest, reaching 1,770 contracts, alongside a trading volume of 608 contracts. The company's delivery volume has also surged by over 256% compared to the 5-day average, indicating increased market activity despite underperforming its sector.
Mankind Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable increase in open interest today. The latest open interest stands at 1,770 contracts, reflecting a rise of 185 contracts or 11.67% from the previous open interest of 1,585. This uptick in open interest comes alongside a trading volume of 608 contracts, indicating active participation in the market.In terms of financial metrics, Mankind Pharma's underlying value is reported at Rs 2,450, with a total futures value of approximately Rs 1,878.28 lakhs and an options value of around Rs 158,334.52 lakhs, culminating in a total value of Rs 1,908.34 lakhs. Despite this activity, the stock has underperformed its sector by 0.5%, with a 1-day return of -0.64%, compared to the sector's return of -0.17% and the Sensex's return of -0.47%.
Additionally, Mankind Pharma's delivery volume has seen a significant increase, rising by 256.33% against the 5-day average delivery volume, with a total of 3.99 lakh shares delivered on May 30. The stock remains liquid enough for a trade size of Rs 1.63 crore, based on 2% of the 5-day average traded value. Overall, the increase in open interest highlights a shift in market dynamics for Mankind Pharma, reflecting heightened trading activity.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
